Quick Takeaways
- Euler Fund, L.P. filed SCHEDULE 13G for Lyell Immunopharma, Inc. Common Stock (LYEL).
- Disclosed ownership: 6.7%.
- Date of event: 06 Mar 2026.
Euler Fund, L.P. - 06 Mar 2026 SCHEDULE 13G Report for Lyell Immunopharma, Inc. Common Stock (LYEL)
- Filing Manager
- Euler Fund, L.P.
- Reporting Manager
- EULER FUND, L.P.
- Symbol
- LYEL
- Shares outstanding
- 21,259,732 shares
- Disclosed Ownership
- 1,426,528 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G
- Filing time
- 21 Apr 2026, 09:00:03 UTC
- Date of event
- 06 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Euler Fund, L.P. disclosed 6.7% ownership in Lyell Immunopharma, Inc. Common Stock (LYEL) on 06 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Apr 2026, 09:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EULER FUND, L.P. | 6.7% | 1,426,528 | 1,426,528 | 0 | /s/ Alfred Shum | Alfred Shum, President of the General Partner | |
| Euler Managers Limited | 6.7% | 1,426,528 | 1,426,528 | 0 | /s/ Alfred Shum | Alfred Shum, President | |
| Antonis Indianos | 6.7% | 1,426,528 | 1,426,528 | 0 | /s/ Antonis Indianos | Antonis Indianos |